Red Cedar Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,299
Closed -$299K 82
2020
Q4
$299K Sell
1,299
-4,856
-79% -$1.12M 0.04% 82
2020
Q3
$1.56M Buy
6,155
+1,531
+33% +$379K 0.29% 39
2020
Q2
$1.09M Buy
+4,624
New +$1.05M 0.26% 29

Other funds holding AMGN

Red Cedar Investment Management's AMGN Position: Q1 2021 in Review

Red Cedar Investment Management sold out of Amgen (AMGN) in Q1 2021, closing a stake of 1,299 shares — an estimated $299K sold.

Red Cedar Investment Management first reported a position in AMGN in Q2 2020 and held it in 3 quarters. The position peaked at $1.56M in Q3 2020. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q1 2021.

  • Red Cedar Investment Management reported no remaining Amgen position as of Q1 2021 after selling out during the quarter.
  • Red Cedar Investment Management sold 1,299 Amgen shares in Q1 2021, an estimated $299K.
  • Red Cedar Investment Management first reported a position in Amgen in Q2 2020 and held it in 3 quarters.
  • Red Cedar Investment Management's Amgen position peaked at $1.56M in Q3 2020.
  • 2,218 funds tracked by Wall St. Rank held Amgen as of Q1 2021.

Based on Red Cedar Investment Management's 13F filing for Q1 2021, filed 12 May 2021.